Bank Of America Corp Crispr Therapeutics Ag Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Bank Of America Corp holds 941,550 shares of CRSP stock, worth $42.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

941,550

Previous 863,214 9.07%

Holding current value

$42.6 Million

Previous $58.8 Million 13.57%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $4.01 Million - $5.34 Million	78,336 Added 9.07%	941,550 $50.9 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $10.4 Million - $15.3 Million	172,044 Added 24.89%	863,214 $58.8 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $2.45 Million - $4.58 Million	-63,387 Reduced 8.4%	691,170 $43.3 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $10.3 Million - $16.1 Million	236,851 Added 45.75%	754,557 $42.4 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $3.74 Million - $5.12 Million	91,190 Added 21.38%	517,706 $23.4 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $40.9 Million - $68.6 Million	-1,044,166 Reduced 71.0%	426,516 $17.3 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $14.9 Million - $20.4 Million	243,970 Added 19.89%	1,470,682 $96.1 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $21.6 Million - $37 Million	500,763 Added 68.98%	1,226,712 $74.5 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $13.9 Million - $20.7 Million	260,739 Added 56.05%	725,949 $45.6 Million
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $26.3 Million - $41.7 Million	-374,563 Reduced 44.6%	465,210 $35.3 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $28.3 Million - $40.2 Million	256,875 Added 44.07%	839,773 $94 Million
Q2 2021 Sep 13, 2021	BUY	$100.84 - $161.89 $58.8 Million - $94.4 Million	582,898 New	582,898 $94.4 Million

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.53B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Crispr Therapeutics Ag Transaction History